Healthpeak Properties, Inc. (DOC)
NYSE: DOC · Real-Time Price · USD
17.54
+0.14 (0.83%)
May 9, 2025, 12:06 PM - Market open
Healthpeak Properties Stock Forecast
Stock Price Forecast
The 11 analysts with 12-month price forecasts for Healthpeak Properties stock have an average target of 23.27, with a low estimate of 21 and a high estimate of 28. The average target predicts an increase of 32.71% from the current stock price of 17.54.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Healthpeak Properties stock from 11 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 3 | 3 | 2 | 2 | 2 |
| Buy | 5 | 6 | 6 | 6 | 6 | 6 |
| Hold | 5 | 5 | 5 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 14 | 14 | 14 | 11 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Argus Research | Argus Research | Strong Buy Reiterates $25 | Strong Buy | Reiterates | $25 | +42.57% | Apr 29, 2025 |
| Baird | Baird | Buy Maintains $24 → $22 | Buy | Maintains | $24 → $22 | +25.46% | Apr 29, 2025 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $23 → $21 | Buy | Maintains | $23 → $21 | +19.76% | Apr 28, 2025 |
| Wedbush | Wedbush | Buy Maintains $24 → $22 | Buy | Maintains | $24 → $22 | +25.46% | Apr 28, 2025 |
| Wedbush | Wedbush | Buy Reiterates $24 | Buy | Reiterates | $24 | +36.87% | Apr 11, 2025 |
Financial Forecast
Revenue This Year
2.81B
from 2.70B
Increased by 3.91%
Revenue Next Year
2.93B
from 2.81B
Increased by 4.31%
EPS This Year
0.22
from 0.36
Decreased by -37.72%
EPS Next Year
0.28
from 0.22
Increased by 26.63%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 3.0B | 3.2B | 3.3B | |
| Avg | 2.8B | 2.9B | 3.0B | |
| Low | 2.6B | 2.7B | 2.9B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 12.0% | 14.3% | 11.7% | |
| Avg | 3.9% | 4.3% | 3.7% | |
| Low | -4.1% | -5.3% | -1.4% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 0.28 | 0.36 | 0.40 | ||
| Avg | 0.22 | 0.28 | 0.29 | ||
| Low | 0.17 | 0.20 | 0.20 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -20.9% | 59.9% | 41.1% | ||
| Avg | -37.7% | 26.6% | 3.6% | ||
| Low | -53.5% | -12.2% | -30.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.